NCT06818773 2025-02-10
Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
Eastern Hepatobiliary Surgery Hospital
Phase 4 Not yet recruiting
Eastern Hepatobiliary Surgery Hospital
Tianjin Medical University Cancer Institute and Hospital
AIO-Studien-gGmbH
Hoffmann-La Roche